ImmuCell
Price & Volume
Stats
See more52W Range | $4.52-$10.75 |
Market Cap | $88.5M |
Shares Short | 10,435 |
Financials
See moreRevenue (12 Mos) | $29.9M |
Revenue Growth (YoY) | 28.4% |
Gross Profit (12 Mos) | $12.7M |
Diluted EPS | -$0.07 |
News
See moreYahoo Finance • 20 days ago
ImmuCell Q1 Earnings Call Highlights
Yahoo Finance • 3 months ago
ImmuCell outlines plan to boost First Defense capacity to 5–6M units while strengthening U.S. market share
Yahoo Finance • 3 months ago
ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2025
Yahoo Finance • 5 months ago
ImmuCell Announces Strategic Focus on First Defense® After Receiving an FDA Incomplete Letter for Re-Tain®
About
CEO | Mr. Paul F. Olivier Te Boekhorst |
CFO | Mr. Timothy C. Fiori |
Address | 56 Evergreen Drive, Portland, ME, United States, 04103 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 73 |